Markus Richard
Chief Medical Officer
Markus Richard has filed 2 SEC Form 4 filings (3 transaction rows) across 1 company, with disclosures dating back to 2025. 2 of those filings fall inside the rolling window. Most recent filing: Jan 26, 2026.
On the most recent filing, Markus Richard is listed as Chief Medical Officer at Arcus Biosciences, Inc. Inside the rolling window, Markus Richard reported no open-market purchases and 2 open-market sales totaling $210K in RCUS. The largest disclosed transaction in the window is a sale of 5,052 RCUS shares on Dec 16, 2025, worth $111K.
Companies traded
Other insiders at RCUS
Insider Buying
$0
reported purchases (SEC code P)
Insider Selling
$210K
reported sales (SEC code S)
Companies
1
in the rolling window
Frequently asked questions
How many SEC Form 4 filings has Markus Richard made?
Markus Richard has filed 2 SEC Form 4 filings (3 transaction rows) across 1 company since 2025.
Which companies does Markus Richard trade?
Markus Richard has filed SEC Form 4 disclosures for 1 company, including RCUS.
When was Markus Richard's most recent SEC Form 4 filing?
Markus Richard's most recent SEC Form 4 filing on Tracefour is dated Jan 26, 2026.
What is Markus Richard's job title?
On the most recent SEC Form 4 filings tracked by Tracefour, Markus Richard is listed as Chief Medical Officer.
What is Markus Richard's total buy and sell value in the current window?
Inside the rolling retention window, Markus Richard bought $0 and sold $210K based on SEC Form 4 filings.
What was Markus Richard's largest disclosed transaction?
The largest disclosed transaction in the current window is a sale of 5,052 RCUS shares on 2025-12-16, worth $111K, per SEC Form 4 filings.